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Original Investigation
Predictors of Overtesting in
Pulmonary Embolism Diagnosis
Safiya Richardson, MD, MPH, Eugene Lucas, MD, Stuart Cohen, MD, Meng Zhang, PhD,
Guang Qiu, MD, PhD, Sundas Khan, MD, Thomas McGinn, MD, MPH
Background: The benefits of computed tomography pulmonary angiography (CTPA) for pulmonary embolism (PE) diagnosis must be
weighed against its risks, radiation-induced malignancy, and contrast-induced nephropathy. Appropriate use of CTPA can be assessed
by monitoring yield, the percentage of tests positive for PE. We identify factors that are associated low CTPA yield, which may predict
overtesting.
Methods: This was a retrospective cohort study of six emergency departments between June 2014 and February 2017. The electronic
health record was queried for CTPAs ordered for adult patients in the emergency department. We assessed the following patient factors:
age, gender, body mass index, number of comorbidities, race, and ethnicity, provider factors: type (resident, fellow, attending, physician
assistant) and environment factors: test time of day, season of visit, and crowdedness of the department.
Results: A total of 14,782 CTPAs were reviewed, of which 1366 were found to be positive for PE, resulting in an overall CTPA yield of
9.24%. Provider type was not associated with a difference in yield. Testing was less likely to be positive in younger patients, females, those
with lower body mass indexes and those identifying as Asian or Hispanic. Testing was also less likely to be positive when ordered during
the overnight shift and during the winter and spring seasons.
Conclusion:Our study identified several patient and environmental factors associated with low CTPA yield suggesting potential targets for
overtesting. Targeting education and clinical decision support to assist providers in these circumstances may meaningfully improve yields.
Key Words: Health informatics; Pulmonary embolism; Electronic health record; Quality improvement; Computed tomography pulmonary
angiography.
© 2019 Published by Elsevier Inc. on behalf of The Association of University Radiologists.
INTRODUCTION
E very year 360,000 Americans are diagnosed with pul-monary embolism (PE) (1,2). This common condi-tion carries a mortality of up to 34% without timely
diagnosis and treatment (3). However, diagnosis is challeng-
ing as the signs and symptoms of PE are nonspecific, often
resulting in low thresholds for imaging (46). Computerized
tomography pulmonary angiography (CTPA) is sensitive and
specific for PE (7); however, it is associated with a median of
10 mSV of radiation, the equivalent of 137 chest x rays (8).
The benefits of CTPA for PE diagnosis however must be
weighed against its risks, radiation-induced malignancy, and
contrast-induced nephropathy (913).
CTPA diagnostic yield, or CTPA yield, is the percentage
of CTPA tests that are positive for PE. This has been
suggested as a metric of appropriateness of use with the Brit-
ish College of Radiologists publishing a target yield of over
15.3% (14). US CTPA yields vary from 6% to 25% across dif-
ferent health care institutions (15,16). Few studies have inves-
tigated factors that are associated with differences in CTPA
yield. Factors found to predict low CTPA yield include
female sex of the patient, for-profit and urban health care set-
tings, and fewer years of provider experience (15,17). Here,
we evaluate the association between various patient, pro-
vider, and environmental factors and CTPA yield to discover
potential predictors of inappropriate testing.
MATERIALS AND METHODS
We performed a multicenter retrospective cohort study by
querying Electronic Health Record (EHR) data for CTPA
testing performed on adults between June 2014 and January
2017. The study took place at six hospitals across a large
health system. The hospitals are supported by the Sunrise
Clinical Manager EHR, a subsidiary of Allscripts Healthcare
Solutions (Chicago, IL). This study was approved by our
health system’s Institutional Review Board.
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Computerized CTPA Yield Calculation
As was previously validated, CTPA yield was calculated as the
number of ED CTPA orders linked to an inpatient discharge
diagnosis of PE divided by the total number CTPAs com-
pleted (18). Our validation study found 96.4% accuracy using
this method which utilizes EHR reports and not billing data.
CTPAs done on the same day as a CTA abdomen/pelvis
were eliminated as these were found in our validation study
to be done only to evaluate for aortic disease and not PE. PE
diagnosis was in accordance with International Classification
of Diseases, Clinical Modification codes, versions 9 and 10
(ICD-9-CM and ICD-10-CM). The full range of PE diag-
nosis codes was used and consisted of the following: 415.0,
415.11, 415.12, 415.13, and 415.19 for ICD-9-CM; and
I26.0, I26.01, I26.02, I26.09, I26.9, I26.90, I26.92, and
I26.99 for ICD-10-CM.
Patient, Provider, and Environment Factors
Data were collected from the EHR based on visit identifica-
tion number. Binomial data collected included patient gen-
der. Continuous data collected included patient age, body
mass index (BMI), and number of documented comorbidities
and were divided into distinct categories. Categorical data
collected included race, ethnicity, time of day in 6 hour inter-
vals, time of year in seasonal 3-month intervals, smoking sta-
tus, ED crowding, and type of provider. The ED was defined
as crowed if the number of patients on the day of CTPA
order exceeded 257, which was the top quartile of ED daily
patients for the study overall.
Data Analysis
Univariate data were assessed with chi-squared or Fisher’s
exact test to explore the association between patient, pro-
vider, and environment factors and CTPA yield. Logistic
regression was performed on the results found initially to be
statistically significant in order to assess for the presence of
confounding. Statistical analysis performed with SAS version
9.6.
RESULTS
A total of 14,782 CTPAs were reviewed, of which 1366
were found to be positive for PE, resulting in an overall
CTPA yield of 9.24%. Distribution of categorical patient data
is included in Table 1. Mean age of patients was 57.3 § 18.8.
Mean BMI for patients was 29.5 § 7.9. Mean number of
comorbidities was 1.46 § 2.27. Missing data included 5
entries for patient gender, 4747 for patient BMI, 36 for pro-
vider type, and 4 for test time of day. As more than 10% of
BMI data were missing, sensitivity analysis was done by
imputing BMI using median (=28.18) to see whether the
association between outcome and BMI would be changed,
and no change was found.
Univariate analysis found CTPA yield to vary by patient
age, gender, BMI, race, and ethnicity and test time of day
and time of year (Table 2). CTPA yield was lower in patients,
who were younger, females, had lower BMIs, and who iden-
tified as Asian or Hispanic. We also found CTPA yields to
TABLE 1. Baseline Characteristics of Patient, Provider, and
Environment
Factors no. (%) CTPA Yield
Patients
Age
1830 1489 (10%) 4.9%
3150 3836 (26%) 7.5%
5170 5469 (37%) 9.8%
>70 3988 (27%) 11.8%
Sex
Female 9630 (65%) 8.4%
Male 5147 (35%) 10.8%
Body mass index
<18.5 278 (3%) 5%
18.524.9 2773 (28%) 10.1%
2529.9 2996 (30%) 13.4%
30 3988 (40%) 13.3%
Number of comorbidities
<5 13,549 (92%) 9.2%
510 1128 (8%) 9.4%
>10 105 (1%) 14.3%
Race
Black 3366 (23%) 10.8%
Asian 1049 (7%) 4%
White 7811 (53%) 10%
Other 2556 (17%) 7.1%
Ethnicity
Hispanic 2008 (14%) 6.5%
Non-Hispanic 12,394 (84%) 9.7%
Declined 380 (3%) 9%
Providers
Provider type
Attending 9527 (65%) 9.2%
Resident 3959 (27%) 9.4%
Fellow 51 (0.3%) 9.8%
Nurse practitioner 116 (0.8%) 12%
Physician assistant 1093 (7%) 8.8%
Environment
ED crowding
Crowded 3296 (22%) 9.9%
Not crowded 1,1486 (78%) 9%
Test time of day
8 am to 1:59 pm (morning) 3619 (24%) 9.2%
2 pm to 7:59 pm (afternoon) 5548 (38%) 10.2%
8 pm to 1:59 am (evening) 3975 (27%) 8.5%
2 am to 8 am (overnight) 1636 (11%) 7.8%
Test time of year
JanuaryMarch (Winter) 3748 (25%) 8.4%
AprilJune (Spring) 3138 (21%) 8.6%
JulySeptember (Summer) 3824 (26%) 9.9%
OctoberDecember (Fall) 4072 (28%) 9.9%
CTPA, computerized tomography pulmonary angiography.
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vary based on test time of day and month of the year. We
found no difference in CTPA yields based on the patient’s
number of comorbidities, how crowded the ED was or the
provider type.
All of these factors remained significant in the logistical
regression analysis. The odds of having a positive CTPA test
were lower for patients age 1830 (OR 0.63), 3150 (OR
0.81), and 5170 (OR 0.81) when these were compared
with patients greater than 70 years old. The odds of having a
positive test were lower in female patients (OR 0.85) and
those with a BMI of <18.5 (OR 0.35) and 18.524.9 (OR
0.74) compared with patients having BMIs greater than or
equal to 30. Asian patients had lower odds of having a posi-
tive test (OR 0.45) while African Americans had higher odds
(OR 1.27) when compared with white patients. Non-
Hispanics had higher odds of having a positive test (OR 1.35).
CTPA testing done during the overnight shift (2 am to 8
am) was less likely to be positive (OR= 0.76) compared with
the afternoon shift (2 pm to 8 pm). When compared with
testing done during the January to March months, higher
CTPA yields were found for tests done during the summer
(JulySeptember; OR= 1.23) and the fall (October
December) seasons (OR = 1.21).
DISCUSSION
Every year about 2.4 million CTPA scans are performed to
evaluate for PE in emergency departments (EDs) in the
United States (19). Each CTPA carries a 14% risk of contrast-
induced nephropathy (20) and a lifetime malignancy risk that
can be as high as 2.8% (21). Incidental findings requiring
diagnostic follow-up are found in 24% of tests, increasing
both costs and harms from repeat imaging (22). A recent
study including 2.5 million Medicare emergency visits found
utilization to have increased fivefold between 2000 and 2009
with diagnostic yield declining (2). This decrease in diagnos-
tic yield has raised concerns about CTPA over testing.
Our overall CTPA yield of 9.24% is comparable to those
reported at other health systems in the United States
(4,15,17,23). We identified several clinical and nonclinical
predictors of low CTPA yield that have never been evaluated
in a comprehensive multivariate analysis. This is the first study
to show lower CTPA yields based on test time. These predic-
tors represent targets for quality improvement.
Age, Sex, and Obesity
Increasing age, male sex, and obesity are all associated with an
increased risk of venous thromboembolism (2427). Previous
studies have also shown increasing age and male sex to corre-
late with higher CTPA yields (28,29). To our knowledge,
ours is the first study to show an association between lower
BMI and yield. Notably, we did not include clinical predictors
of PE from common clinical prediction rules as our goal was
not to predict PE but physician ordering behavior.
Race and Ethnicity
We found lower CTPA yields in Asian and Hispanic patients.
Previous direct comparison studies have found that Asians
and Hispanics have lower rates of venous thromboembolism
(3033). This finding represents a health disparity where
Asian and Hispanic patients are being significantly overtested
for PE, with more unnecessary exposure to radiation. Nota-
bly, Asian and Hispanic patients might have been more likely
to have limited English proficiency which is associated with
lower CTPA yields when interpreters are not utilized (34).
We did not have access to English language proficiency in
our data set.
TABLE 2. Factors Associated With Positive CTPA
Factors Adjusted OR
(95% CI)a
p Valueb
Patients
Age
1830 0.63 (0.480.84) 0.001
3150 0.81 (0.680.96) 0.01
5170 0.81 (0.750.97) 0.006
>70 1 [Reference]
Sex
Female 0.85 (0.750.97) 0.01
Body mass index
<18.5 0.35 (0.200.61) 0.002
18.524.9 0.74 (0.630.87) 0.002
2529.9 1.01 (0.871.16) 0.93
30 1 [Reference]
Race
African American 1.27 (1.101.47) 0.002
Asian 0.45 (0.320.63) <0.001
Other 0.85 (0.71.05) 0.13
White 1 [Reference]
Ethnicity
Non-Hispanic 1.35 (1.071.7) 0.01
Hispanic 1 [Reference]
Environment
Test time of day
8 am to 1:59 pm 0.9 (0.771.05) 0.2
2 pm to 7:59 pm 1 [Reference]
8 pm to 1:59 am 0.9 (0.771.05) 0.17
2 am to 8 am 0.76 (0.610.94) 0.01
Test time of year
JanuaryMarch (Winter) 1 [Reference]
AprilJune (Spring) 1.04 (0.861.25) 0.68
JulySeptember (Summer) 1.23 (1.041.46) 0.02
OctoberDecember (Fall) 1.21 (1.021.43) 0.03
OR, odds ratio.
The bold values are those less than<0.05
a Adjusted model included all characteristics reported in the table.
b p < 0.05 was the threshold for statistical significance.
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Test Time
Our results identified lower yields during the overnight shift,
between 2 am and 8 am. This is the first study to show lower
CTPA yields based on test time. These results fit into litera-
ture demonstrating that provider’s decisions are subject vari-
ability based on emotional and psychological factors. For
example, providers are more likely to prescribe antibiotics
during the later hours of their clinic sessions (35).
Season
With regard to time of year, our data also identified signifi-
cant CTPA yield variation. Specifically, CTPA yields were
higher in the months July through December when com-
pared with January through March. To our knowledge, no
significant data exist on the relationship between test time of
year and CTPA yield. There is no significant seasonal vari-
ability in PE incidence (36). Our results can be explained by
higher incidences of influenza and other respiratory infections
during the winter and early spring that present in similar ways
to PE (37).
Future Directions—Targeted Clinical Decision Support
Clinical prediction rules such as Well’s Score for Pulmonary
Embolism and the Geneva Score assist providers in determin-
ing pretest probability of PE. Meta-analysis of the effect of
Well’s Score for Pulmonary Embolism has shown average
CTPA yield to increase from 9% to 12% (38). This corre-
sponds to about a 25% decrease in unnecessary CTPA scans
without missing PEs. However, studies suggest these tools are
not commonly used with inappropriate CTPA utilization
occurring in 4571% of cases (4,6,39).
The use of clinical decision support to improve testing
behaviors in the diagnosis of PE has shown similar improve-
ments in CTPA yields; however, they also have low accept-
ability among providers (40). Meta-analyses of clinical
decision support overall have found provider adoption of
these tools to be low (41) with up to 96% being overridden
(42). Alert fatigue is a major reason for low acceptability
among providers (43). With targeted clinical decision sup-
port, we can address areas of low performance while reducing
overall amounts of tool triggering. Our study results can be
used to inform the targeting of quality improvement efforts,
including education clinical decision support.
Limitations
Our method for calculating CTPA yield in the ED depends
on an inpatient diagnosis of PE. In the rare, but potentially
growing, number of cases in which a patient is diagnosed
with PE, but discharged directly from the ED, our methodol-
ogy would lead us to interpret this situation as a negative
CTPA, falsely decreasing CTPA yield. This was a rare occur-
rence however in our validation study (44). Additionally, in
the rare case that a provider orders a CTPA as well as a CTA
abdomen/pelvis to evaluate for both PE and aortic disease
the study would be eliminated. This was not found to occur
in our validation study. With regard to Asian and Hispanic
patients, we were not able to ascertain whether a language
barrier played a role in lowering CTPA yield.
CONCLUSION
Our study investigated CTPA yield variation with respect to
patient, provider, and environmental factors. Among the
results, patient age, BMI, gender, race, and ethnicity were
predictors of CTPA yield. Additionally, studies done during
the overnight shift, and during the winter and spring seasons
were less likely to be positive. Further research might assess
the impact of using these predictors to target quality
improvement efforts to increase overall CTPA yields.
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